Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,204 | 61,038,701 | 1.60% | 2.98% | 5.69% | -6.72% | -5.08% | 8.56% |
| Healthcare | HEALTHCARE | Sector | 1,203 | 6,190,744 | 1.62% | 0.69% | -1.64% | -7.48% | -8.50% | -4.01% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 629 | 2,964,484 | 1.84% | 0.26% | 0.38% | -3.93% | -7.17% | -5.85% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 299 | 1,273,444 | 2.60% | -3.42% | 3.86% | -4.11% | -6.93% | 3.99% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 98 | 91,685 | 2.01% | 5.42% | 5.38% | -17.15% | -20.51% | -16.84% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 2,486 | 2.33% | 1.22% | -10.29% | -19.45% | 0.95% | -12.55% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,733 | 1.54% | 2.40% | -6.79% | -21.65% | -10.30% | 0.17% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 18,097 | 2.15% | 3.95% | -5.93% | -13.21% | -31.82% | -42.84% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 7,279 | 2.45% | 8.35% | -5.05% | -1.57% | 6.07% | 8.83% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 2,313 | 1.78% | 15.17% | -3.51% | -39.41% | -54.72% | -43.13% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 5,239 | 3.92% | 14.15% | -2.66% | 3.32% | 20.79% | 32.36% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 1,831 | 1.20% | 1.92% | 0.06% | -12.10% | -5.82% | 9.18% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,429 | 82,466,165 | 1.48% | 2.93% | 0.40% | -4.90% | -1.66% | 14.71% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 3,088 | 0.46% | 0.30% | 1.14% | -17.83% | 9.77% | 119.99% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 10,902 | 2.90% | 2.76% | 1.26% | -26.93% | -11.78% | -23.32% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 3,003 | 2.35% | 5.93% | 1.55% | 9.81% | 15.21% | 63.42% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 6,154 | 1.16% | 5.08% | 1.66% | -44.20% | -50.30% | -51.48% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 5,461 | -0.03% | 5.59% | 2.24% | 4.45% | 25.43% | 49.83% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 3,881 | 0.87% | 0.85% | 3.27% | -0.12% | 22.85% | 46.22% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 98 | 91,685 | 2.01% | 5.42% | 5.38% | -17.15% | -20.51% | -16.84% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 782 | 5.73% | 11.78% | 8.43% | -49.86% | -42.53% | -27.05% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 1,604 | 1.38% | 13.95% | 8.96% | -40.04% | -49.25% | -11.05% |
| Anavex Life Sciences Corp. | AVXL:USAAVXL:USA | Stock | 1 | 795 | 0.54% | -0.64% | 9.35% | 8.33% | 63.92% | 153.66% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 593 | 5.76% | 19.52% | 9.52% | -36.69% | 36.73% | -4.69% |
| Mind Medicine (MindMed), Inc. | MNMD:USAMNMD:USA | Stock | 1 | 520 | 5.16% | 11.24% | 16.08% | -5.97% | 9.31% | -26.51% |
| Denali Therapeutics, Inc. | DNLI:USADNLI:USA | Stock | 1 | 2,345 | 2.37% | 4.85% | 19.65% | -24.73% | -38.77% | 1.73% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 1,213 | -1.08% | 7.23% | 19.68% | -14.49% | -59.38% | -54.08% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 675 | 0.00% | 0.14% | 21.50% | -1.68% | -22.39% | -3.68% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 2,925 | 0.50% | 1.75% | 21.68% | -3.21% | -8.62% | -9.91% |
| Capricor Therapeutics, Inc. | CAPR:USACAPR:USA | Stock | 1 | 541 | -6.91% | -8.98% | 21.77% | -21.87% | -44.48% | 122.51% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 520 | -2.43% | -1.33% | 45.91% | -16.41% | -22.96% | -16.70% |
| REGENXBIO, Inc. | RGNX:USARGNX:USA | Stock | 1 | 515 | 5.80% | 13.66% | 47.52% | 32.99% | 17.65% | -35.80% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 529 | 7.05% | 46.59% | 95.45% | 68.63% | 37.97% | 6.61% |
* Colors indicate performance relative to the benchmark.